UCSF Database for the Advancement of JMML - Integration of Metadata with Omic Data

Request Access

The Genomic Landscape of Juvenile Myelomonocytic Leukemia

Elliot Stieglitz, A. Taylor-Weiner, Tiffany Y. Chang, et al. (2015). Nature genetics. Cited 254 times. https://doi.org/10.1038/ng.3400

Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia

Elliot Stieglitz, T. Mazor, A. Olshen, et al. (2017). Nature Communications. Cited 76 times. https://doi.org/10.1038/s41467-017-02178-9

Phase II/III trial of a pre‐transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: A report from the Children's Oncology Group

Elliot Stieglitz, Ashley F. Ward, R. Gerbing, et al. (2015). Pediatric Blood & Cancer. Cited 49 times. https://doi.org/10.1002/pbc.25342

International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia

M. Schönung, Julia A. Meyer, P. Nöllke, et al. (2020). Clinical Cancer Research. Cited 38 times. https://doi.org/10.1158/1078-0432.CCR-20-3184

Fusion driven JMML: a novel CCDC88C–FLT3 fusion responsive to sorafenib identified by RNA sequencing

Alexander K. Chao, Julia A. Meyer, Alex G. Lee, et al. (2019). Leukemia. Cited 32 times. https://doi.org/10.1038/s41375-019-0549-y

Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study

C. Dvorak, P. Satwani, Elliot Stieglitz, et al. (2018). Pediatric Blood & Cancer. Cited 31 times. https://doi.org/10.1002/pbc.27034

Molecular and phenotypic diversity of CBLmutated juvenile myelomonocytic leukemia

A. Hecht, Julia A. Meyer, Astrid Behnert, et al. (2020). Haematologica. Cited 27 times. https://doi.org/10.3324/haematol.2020.270595

Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia

A. Hecht, Julia A. Meyer, F. Chehab, et al. (2019). Pediatric Blood & Cancer. Cited 17 times. https://doi.org/10.1002/pbc.27948

NUP98-NSD1 Driven MDS/MPN in Childhood Masquerading as JMML

Astrid Behnert, Alex G. Lee, Elizabeth Young, et al. (2020). Journal of Pediatric Hematology/Oncology. Cited 7 times. https://doi.org/10.1097/MPH.0000000000001913

Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group.

Elliot Stieglitz, Alex G. Lee, Steven P. Angus, et al. (2024). Cancer discovery. Cited 5 times. https://doi.org/10.1158/2159-8290.CD-23-1376

LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia

Astrid Wintering, A. Hecht, Julia A. Meyer, et al. (2023). Haematologica. Cited 2 times. https://doi.org/10.3324/haematol.2023.283776